Into 2021 Medtechs Prioritize Third-Wave Coronavirus Readiness
If Necessity Is The Mother Of Invention, Then Healthtech Firms Know What Is Expected Of Them In 2021 – How They Achieve It Will Be Anything But Straightforward
Executive Summary
Coronavirus has definitively changed health care delivery and the perceptions of health technologies and digital ecosystems. Industry will need to adjust to the aftermath of COVID-19, take opportunities and learn lessons from 2020 or 2021 could be every inch as challenging.
You may also be interested in...
Using ‘Big’ For Good In The COVID-19 Challenge
Johnson & Johnson, among world’s largest health care groups, explains how the global medtech business should change, seen through the lens of the coronavirus pandemic.
EU MDR Compliance Will Cost More Than 5% Of Revenues For Half Of Medtechs, Survey Says
Almost half of companies polled on extra resources needed to comply with the EU Medical Device Regulation are preparing for considerable outlay. Manufacturers are also falling short in digital readiness.
A Legal Firm’s View Of Investor Opportunities
CMS patent attorneys Jane Hollywood and Rob Stephen say COVID-19 has not dented the enthusiasm of medtech start-up entrepreneurs from pushing back the technology boundaries in patient care delivery – in fact, they are getting younger.
Need a specific report? 1000+ reports available
Buy Reports